{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T22:28:43Z","timestamp":1791325723272,"version":"4.3.1"},"reference-count":51,"publisher":"American Society of Hematology","issue":"6","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2013,8,8]]},"abstract":"<jats:title>Key Points<\/jats:title>\n                  <jats:p>BTLA-HVEM interaction negatively regulates the proliferation of LT\u03b3\u03b4. BTLA-HVEM interaction appears as a new possible mechanism of immune escape by lymphoma cells.<\/jats:p>","DOI":"10.1182\/blood-2012-11-464685","type":"journal-article","created":{"date-parts":[[2013,5,22]],"date-time":"2013-05-22T00:38:42Z","timestamp":1369183122000},"page":"922-931","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":98,"title":["The co-receptor BTLA negatively regulates human V\u03b39V\u03b42 T-cell proliferation: a potential way of immune escape for lymphoma cells"],"prefix":"10.1182","volume":"122","author":[{"given":"Julie","family":"Gertner-Dardenne","sequence":"first","affiliation":[{"name":"Institut National de la Sant\u00e9 Et de la Recherche Scientifique, U1068, Centre de Recherche en Canc\u00e9rologie de Marseille, Immunity & Cancer, Marseille, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyril","family":"Fauriat","sequence":"additional","affiliation":[{"name":"Institut National de la Sant\u00e9 Et de la Recherche Scientifique, U1068, Centre de Recherche en Canc\u00e9rologie de Marseille, Immunity & Cancer, Marseille, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Orlanducci","sequence":"additional","affiliation":[{"name":"Institut Paoli Calmettes, Marseille, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Laure","family":"Thibult","sequence":"additional","affiliation":[{"name":"Institut National de la Sant\u00e9 Et de la Recherche Scientifique, U1068, Centre de Recherche en Canc\u00e9rologie de Marseille, Immunity & Cancer, Marseille, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Pastor","sequence":"additional","affiliation":[{"name":"Institut National de la Sant\u00e9 Et de la Recherche Scientifique, U1068, Centre de Recherche en Canc\u00e9rologie de Marseille, Immunity & Cancer, Marseille, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jude","family":"Fitzgibbon","sequence":"additional","affiliation":[{"name":"Barts Cancer Institute, Cancer Research UK Centre of Excellence, John Vane Science Centre, Queen Mary University of London, London, United Kingdom; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reda","family":"Bouabdallah","sequence":"additional","affiliation":[{"name":"Aix-Marseille University, Marseille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Xerri","sequence":"additional","affiliation":[{"name":"Institut National de la Sant\u00e9 Et de la Recherche Scientifique, U1068, Centre de Recherche en Canc\u00e9rologie de Marseille, Immunity & Cancer, Marseille, France;"},{"name":"Institut Paoli Calmettes, Marseille, France;"},{"name":"Aix-Marseille University, Marseille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Olive","sequence":"additional","affiliation":[{"name":"Institut National de la Sant\u00e9 Et de la Recherche Scientifique, U1068, Centre de Recherche en Canc\u00e9rologie de Marseille, Immunity & Cancer, Marseille, France;"},{"name":"Institut Paoli Calmettes, Marseille, France;"},{"name":"Aix-Marseille University, Marseille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"5156","key":"2019111817241409500_B1","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1126\/science.8146660","article-title":"Stimulation of human gamma delta T cells by nonpeptidic mycobacterial ligands.","volume":"264","author":"Constant","year":"1994","journal-title":"Science"},{"issue":"3","key":"2019111817241409500_B2","doi-asserted-by":"crossref","first-page":"998","DOI":"10.4049\/jimmunol.154.3.998","article-title":"V gamma 2V delta 2 TCR-dependent recognition of non-peptide antigens and Daudi cells analyzed by TCR gene transfer.","volume":"154","author":"Bukowski","year":"1995","journal-title":"J Immunol"},{"issue":"11","key":"2019111817241409500_B3","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1002\/eji.1830271111","article-title":"Control of self-reactive cytotoxic T lymphocytes expressing gamma delta T cell receptors by natural killer inhibitory receptors.","volume":"27","author":"Halary","year":"1997","journal-title":"Eur J Immunol"},{"issue":"5","key":"2019111817241409500_B4","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1002\/1521-4141(200105)31:5<1628::AID-IMMU1628>3.0.CO;2-T","article-title":"Differential activation of human gammadelta cells by nonpeptide phosphoantigens.","volume":"31","author":"Sireci","year":"2001","journal-title":"Eur J Immunol"},{"issue":"2","key":"2019111817241409500_B5","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1084\/jem.20021500","article-title":"Human T cell receptor gammadelta cells recognize endogenous mevalonate metabolites in tumor cells.","volume":"197","author":"Gober","year":"2003","journal-title":"J Exp Med"},{"issue":"4","key":"2019111817241409500_B6","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/1074-7613(95)90178-7","article-title":"Direct presentation of nonpeptide prenyl pyrophosphate antigens to human gamma delta T cells.","volume":"3","author":"Morita","year":"1995","journal-title":"Immunity"},{"issue":"1","key":"2019111817241409500_B7","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1006\/clin.1993.1040","article-title":"V delta 2+ gamma delta T lymphocytes are cytotoxic to the MCF 7 breast carcinoma cell line and can be detected among the T cells that infiltrate breast tumors.","volume":"67","author":"Bank","year":"1993","journal-title":"Clin Immunol Immunopathol"},{"issue":"5","key":"2019111817241409500_B8","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/00002371-200009000-00004","article-title":"Human gammadelta T lymphocytes exert natural and IL-2-induced cytotoxicity to neuroblastoma cells.","volume":"23","author":"Schilbach","year":"2000","journal-title":"J Immunother"},{"issue":"3","key":"2019111817241409500_B9","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.4049\/jimmunol.174.3.1338","article-title":"Phosphostim-activated gamma delta T cells kill autologous metastatic renal cell carcinoma.","volume":"174","author":"Viey","year":"2005","journal-title":"J Immunol"},{"issue":"8","key":"2019111817241409500_B10","doi-asserted-by":"crossref","first-page":"5481","DOI":"10.4049\/jimmunol.175.8.5481","article-title":"V gamma 9V delta 2 T cell response to colon carcinoma cells.","volume":"175","author":"Corvaisier","year":"2005","journal-title":"J Immunol"},{"issue":"5","key":"2019111817241409500_B11","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1097\/01.ju.0000154355.45816.0b","article-title":"Ex vivo expanded human Vgamma9Vdelta2+ gammadelta-T cells mediate innate antitumor activity against human prostate cancer cells in vitro.","volume":"173","author":"Liu","year":"2005","journal-title":"J Urol"},{"issue":"1","key":"2019111817241409500_B12","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1182\/blood-2002-12-3665","article-title":"Gammadelta T cells for immune therapy of patients with lymphoid malignancies.","volume":"102","author":"Wilhelm","year":"2003","journal-title":"Blood"},{"issue":"20","key":"2019111817241409500_B13","doi-asserted-by":"crossref","first-page":"4875","DOI":"10.1182\/blood-2008-08-172296","article-title":"Bromohydrin pyrophosphate enhances antibody-dependent cell-mediated cytotoxicity induced by therapeutic antibodies.","volume":"113","author":"Gertner-Dardenne","year":"2009","journal-title":"Blood"},{"issue":"6","key":"2019111817241409500_B14","doi-asserted-by":"crossref","first-page":"3260","DOI":"10.4049\/jimmunol.0903454","article-title":"V gamma 9V delta 2 T lymphocytes efficiently recognize and kill zoledronate-sensitized, imatinib-sensitive, and imatinib-resistant chronic myelogenous leukemia cells.","volume":"184","author":"D\u2019Asaro","year":"2010","journal-title":"J Immunol"},{"issue":"1","key":"2019111817241409500_B15","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.imlet.2007.03.002","article-title":"Human gammadelta T lymphocytes strip and kill tumor cells simultaneously.","volume":"110","author":"Gertner","year":"2007","journal-title":"Immunol Lett"},{"issue":"41","key":"2019111817241409500_B16","doi-asserted-by":"crossref","first-page":"14741","DOI":"10.1073\/pnas.0507520102","article-title":"gammadelta T cell homeostasis is established in competition with alphabeta T cells and NK cells.","volume":"102","author":"French","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019111817241409500_B17","article-title":"Expression and function of PD-1 in human \u03b3\u03b4 T cells that recognize phosphoantigens.","author":"Iwasaki","year":"2010","journal-title":"Eur J Immunol"},{"issue":"7","key":"2019111817241409500_B18","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/ni944","article-title":"BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1.","volume":"4","author":"Watanabe","year":"2003","journal-title":"Nat Immunol"},{"issue":"1","key":"2019111817241409500_B19","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/ni1144","article-title":"B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator.","volume":"6","author":"Sedy","year":"2005","journal-title":"Nat Immunol"},{"issue":"8","key":"2019111817241409500_B20","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1002\/art.23674","article-title":"Development of autoimmune hepatitis-like disease and production of autoantibodies to nuclear antigens in mice lacking B and T lymphocyte attenuator.","volume":"58","author":"Oya","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"10","key":"2019111817241409500_B21","doi-asserted-by":"crossref","first-page":"5931","DOI":"10.4049\/jimmunol.172.10.5931","article-title":"An inhibitory Ig superfamily protein expressed by lymphocytes and APCs is also an early marker of thymocyte positive selection.","volume":"172","author":"Han","year":"2004","journal-title":"J Immunol"},{"issue":"2","key":"2019111817241409500_B22","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/ni1418","article-title":"B and T lymphocyte attenuator regulates CD8+ T cell-intrinsic homeostasis and memory cell generation.","volume":"8","author":"Krieg","year":"2007","journal-title":"Nat Immunol"},{"issue":"42","key":"2019111817241409500_B23","doi-asserted-by":"crossref","first-page":"27548","DOI":"10.1074\/jbc.273.42.27548","article-title":"Herpesvirus entry mediator ligand (HVEM-L), a novel ligand for HVEM\/TR2, stimulates proliferation of T cells and inhibits HT29 cell growth.","volume":"273","author":"Harrop","year":"1998","journal-title":"J Biol Chem"},{"issue":"10","key":"2019111817241409500_B24","doi-asserted-by":"crossref","first-page":"6420","DOI":"10.4049\/jimmunol.175.10.6420","article-title":"Functional analysis of B and T lymphocyte attenuator engagement on CD4+ and CD8+ T cells.","volume":"175","author":"Krieg","year":"2005","journal-title":"J Immunol"},{"key":"2019111817241409500_B25","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0065-2776(06)92004-5","article-title":"BTLA and HVEM cross talk regulates inhibition and costimulation.","volume":"92","author":"Gavrieli","year":"2006","journal-title":"Adv Immunol"},{"issue":"1","key":"2019111817241409500_B26","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1172\/JCI40070","article-title":"BTLA mediates inhibition of human tumor-specific CD8+ T cells that can be partially reversed by vaccination.","volume":"120","author":"Derr\u00e9","year":"2010","journal-title":"J Clin Invest"},{"issue":"1","key":"2019111817241409500_B27","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1172\/JCI41811","article-title":"Putting the brakes on BTLA in T cell-mediated cancer immunotherapy.","volume":"120","author":"Paulos","year":"2010","journal-title":"J Clin Invest"},{"issue":"9","key":"2019111817241409500_B28","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nri1917","article-title":"Balancing co-stimulation and inhibition with BTLA and HVEM.","volume":"6","author":"Murphy","year":"2006","journal-title":"Nat Rev Immunol"},{"issue":"7","key":"2019111817241409500_B29","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.4049\/jimmunol.176.7.3909","article-title":"Cutting edge: B and T lymphocyte attenuator and programmed death receptor-1 inhibitory receptors are required for termination of acute allergic airway inflammation.","volume":"176","author":"Deppong","year":"2006","journal-title":"J Immunol"},{"issue":"6","key":"2019111817241409500_B30","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1084\/jem.20071160","article-title":"A crucial role for HVEM and BTLA in preventing intestinal inflammation.","volume":"205","author":"Steinberg","year":"2008","journal-title":"J Exp Med"},{"issue":"4","key":"2019111817241409500_B31","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.bbrc.2006.03.242","article-title":"Expression and function of the B and T lymphocyte attenuator (BTLA\/CD272) on human T cells.","volume":"344","author":"Otsuki","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"2019111817241409500_B32","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.4049\/jimmunol.0902487","article-title":"B and T lymphocyte attenuator is highly expressed on CMV-specific T cells during infection and regulates their function.","volume":"185","author":"Serriari","year":"2010","journal-title":"J Immunol"},{"issue":"4","key":"2019111817241409500_B33","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1309\/AJCPPHKGYYGGL39C","article-title":"High expression of the inhibitory receptor BTLA in T-follicular helper cells and in B-cell small lymphocytic lymphoma\/chronic lymphocytic leukemia.","volume":"132","author":"M\u2019Hidi","year":"2009","journal-title":"Am J Clin Pathol"},{"issue":"9","key":"2019111817241409500_B34","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1002\/eji.200939069","article-title":"A role for HVEM, but not lymphotoxin-beta receptor, in LIGHT-induced tumor cell death and chemokine production.","volume":"39","author":"Pasero","year":"2009","journal-title":"Eur J Immunol"},{"issue":"22","key":"2019111817241409500_B35","doi-asserted-by":"crossref","first-page":"9166","DOI":"10.1158\/0008-5472.CAN-10-2460","article-title":"Acquired TNFRSF14 mutations in follicular lymphoma are associated with worse prognosis.","volume":"70","author":"Cheung","year":"2010","journal-title":"Cancer Res"},{"issue":"3","key":"2019111817241409500_B36","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/leu.2011.266","article-title":"High rate of TNFRSF14 gene alterations related to 1p36 region in de novo follicular lymphoma and impact on prognosis.","volume":"26","author":"Launay","year":"2012","journal-title":"Leukemia"},{"issue":"7","key":"2019111817241409500_B37","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.humpath.2007.11.012","article-title":"Programmed death 1 is a marker of angioimmunoblastic T-cell lymphoma and B-cell small lymphocytic lymphoma\/chronic lymphocytic leukemia.","volume":"39","author":"Xerri","year":"2008","journal-title":"Hum Pathol"},{"issue":"3","key":"2019111817241409500_B38","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1084\/jem.20030235","article-title":"Differentiation of effector\/memory Vdelta2 T cells and migratory routes in lymph nodes or inflammatory sites.","volume":"198","author":"Dieli","year":"2003","journal-title":"J Exp Med"},{"issue":"5","key":"2019111817241409500_B39","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/intimm\/8.5.765","article-title":"Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes.","volume":"8","author":"Agata","year":"1996","journal-title":"Int Immunol"},{"issue":"2","key":"2019111817241409500_B40","doi-asserted-by":"crossref","first-page":"711","DOI":"10.4049\/jimmunol.170.2.711","article-title":"Program death-1 engagement upon TCR activation has distinct effects on costimulation and cytokine-driven proliferation: attenuation of ICOS, IL-4, and IL-21, but not CD28, IL-7, and IL-15 responses.","volume":"170","author":"Bennett","year":"2003","journal-title":"J Immunol"},{"issue":"3","key":"2019111817241409500_B41","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/1521-4141(200203)32:3<634::AID-IMMU634>3.0.CO;2-9","article-title":"PD-1:PD-L inhibitory pathway affects both CD4(+) and CD8(+) T cells and is overcome by IL-2.","volume":"32","author":"Carter","year":"2002","journal-title":"Eur J Immunol"},{"issue":"47","key":"2019111817241409500_B42","doi-asserted-by":"crossref","first-page":"39553","DOI":"10.1074\/jbc.M507629200","article-title":"Attenuating lymphocyte activity: the crystal structure of the BTLA-HVEM complex.","volume":"280","author":"Compaan","year":"2005","journal-title":"J Biol Chem"},{"issue":"10","key":"2019111817241409500_B43","doi-asserted-by":"crossref","first-page":"5813","DOI":"10.4049\/jimmunol.162.10.5813","article-title":"CTLA-4-Mediated inhibition of early events of T cell proliferation.","volume":"162","author":"Brunner","year":"1999","journal-title":"J Immunol"},{"issue":"2","key":"2019111817241409500_B44","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/1521-4141(200202)32:2<366::AID-IMMU366>3.0.CO;2-5","article-title":"CTLA-4 regulates cell cycle progression during a primary immune response.","volume":"32","author":"Greenwald","year":"2002","journal-title":"Eur J Immunol"},{"issue":"3","key":"2019111817241409500_B45","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.4049\/jimmunol.0903369","article-title":"Cutting edge: CTLA-4\u2014B7 interaction suppresses Th17 cell differentiation.","volume":"185","author":"Ying","year":"2010","journal-title":"J Immunol"},{"issue":"15","key":"2019111817241409500_B46","doi-asserted-by":"crossref","first-page":"6244","DOI":"10.1073\/pnas.0902115106","article-title":"Unconventional ligand activation of herpesvirus entry mediator signals cell survival.","volume":"106","author":"Cheung","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"2019111817241409500_B47","doi-asserted-by":"crossref","first-page":"7286","DOI":"10.4049\/jimmunol.0902490","article-title":"T cell intrinsic heterodimeric complexes between HVEM and BTLA determine receptivity to the surrounding microenvironment.","volume":"183","author":"Cheung","year":"2009","journal-title":"J Immunol"},{"issue":"3","key":"2019111817241409500_B48","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.4049\/jimmunol.156.3.1006","article-title":"CD28 expression is not essential for positive and negative selection of thymocytes or peripheral T cell tolerance.","volume":"156","author":"Walunas","year":"1996","journal-title":"J Immunol"},{"issue":"6","key":"2019111817241409500_B49","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1084\/jem.183.6.2533","article-title":"CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells.","volume":"183","author":"Krummel","year":"1996","journal-title":"J Exp Med"},{"issue":"10","key":"2019111817241409500_B50","doi-asserted-by":"crossref","first-page":"6073","DOI":"10.4049\/jimmunol.178.10.6073","article-title":"Unexpected role of B and T lymphocyte attenuator in sustaining cell survival during chronic allostimulation.","volume":"178","author":"Hurchla","year":"2007","journal-title":"J Immunol"},{"issue":"5","key":"2019111817241409500_B51","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.4049\/jimmunol.181.5.2973","article-title":"B and T lymphocyte attenuator regulates T cell survival in the lung.","volume":"181","author":"Deppong","year":"2008","journal-title":"J Immunol"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/122\/6\/922\/1375096\/922.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/122\/6\/922\/1375096\/922.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T17:27:31Z","timestamp":1688232451000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/122\/6\/922\/32224\/The-coreceptor-BTLA-negatively-regulates-human"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,8]]},"references-count":51,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,8,8]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2012-11-464685","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,8]]}}}